GlassScriptPhysician profile
Nidhi G Huff
NPI 1659515864
$4,751.25
in general payments reported to CMS, 2019-2025
46 companies · $978 in 2025
The $978 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $174 · 2021: $341 · 2022: $562 · 2023: $709 · 2024: $955 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $871.63 | 2019-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $620.57 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $371.70 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $308.20 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Grifols USA, LLC | $269.27 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $188.91 | 2019-2021 | |
| Electromed, INC. | $186.71 | 2019-2023 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $174.35 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $145.43 | 2019-2025 | |
| Amgen INC. | $126.10 | 2022-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $124.54 | 2022-2025 | Uptravi, Opsumit |
| Insmed, INC. | $113.87 | 2019-2025 | Arikayce |
| Boston Scientific Corporation | $113.69 | 2021 | |
| Merck Sharp & Dohme LLC | $90.27 | 2019-2024 | Winrevair |
| Abiomed | $88.24 | 2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $87.66 | 2019-2025 | Giapreza |
| Ani Pharmaceuticals, INC. | $67.72 | 2024-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $59.37 | 2023-2025 | Acthar |
| Verona Pharma, INC. | $57.26 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $56.17 | 2019-2025 | Tyvaso |
| Harmony Biosciences LLC | $51.80 | 2023-2024 | Wakix |
| Pulmonx Corporation | $48.03 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| 3b Medical, INC. | $47.10 | 2024 | Luna |
| Shire North American Group INC | $40.88 | 2019 | |
| Baxter Healthcare | $40.42 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Seagen INC. | $34.07 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $25.52 | 2025 | Lumryz |
| Viatris Specialty LLC | $25.13 | 2025 | Yupelri |
| Stryker Corporation | $22.19 | 2025 | Flowtriever |
| Fisher & Paykel Healthcare INC | $21.87 | 2024 | Fisher & Paykel Healthcare |
| Advanced Respiratory, INC | $20.26 | 2021 | |
| Gilead Sciences, INC. | $20.00 | 2022 | |
| Philips North America LLC | $19.42 | 2019 | |
| Axsome Therapeutics, INC. | $19.30 | 2025 | Sunosi |
| Bard Peripheral Vascular, INC. | $18.96 | 2023 | |
| Inari Medical, INC. | $18.85 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $18.43 | 2023 | |
| Daiichi Sankyo INC. | $17.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.74 | 2025 | |
| Olympus America INC. | $16.34 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.93 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.28 | 2023 | Cinqair |
| Mylan Specialty L.P. | $14.74 | 2021 | |
| Array Biopharma INC | $14.64 | 2020 | |
| Abbvie INC. | $13.35 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhi Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.